Biotech Stocks

Cytokinetics brings patent suit against Bristol Myers Squibb, escalating rivalry

Endpoints News 1h ago

Cytokinetics and Bristol Myers Squibb are fierce market rivals. Now they’re also rivals in court. Cytokinetics filed a lawsuit against Bristol Myers on Wednesday, seeking to invalidate a recently granted patent protecting ...

Discussion

Sign in to join the discussion. Comments loading…